Bradley Foster & Sargent’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $251K | Hold |
479
| – | – | ﹤0.01% | 487 |
|
2025
Q1 | $304K | Sell |
479
-129
| -21% | -$81.8K | 0.01% | 401 |
|
2024
Q4 | $433K | Sell |
608
-1,300
| -68% | -$926K | 0.01% | 376 |
|
2024
Q3 | $2.01M | Buy |
1,908
+45
| +2% | +$47.3K | 0.03% | 200 |
|
2024
Q2 | $1.96M | Hold |
1,863
| – | – | 0.04% | 197 |
|
2024
Q1 | $1.79M | Sell |
1,863
-74
| -4% | -$71.2K | 0.03% | 215 |
|
2023
Q4 | $1.7M | Sell |
1,937
-24
| -1% | -$21.1K | 0.03% | 218 |
|
2023
Q3 | $1.41M | Hold |
1,961
| – | – | 0.03% | 236 |
|
2023
Q2 | $1.41M | Hold |
1,961
| – | – | 0.03% | 236 |
|
2023
Q1 | $1.61M | Hold |
1,961
| – | – | 0.04% | 201 |
|
2022
Q4 | $1.42M | Hold |
1,961
| – | – | 0.04% | 210 |
|
2022
Q3 | $1.35M | Hold |
1,961
| – | – | 0.04% | 199 |
|
2022
Q2 | $1.16M | Buy |
1,961
+780
| +66% | +$461K | 0.03% | 224 |
|
2022
Q1 | $825K | Buy |
1,181
+610
| +107% | +$426K | 0.02% | 284 |
|
2021
Q4 | $361K | Hold |
571
| – | – | 0.01% | 369 |
|
2021
Q3 | $346K | Buy |
571
+62
| +12% | +$37.6K | 0.01% | 348 |
|
2021
Q2 | $284K | Buy |
509
+5
| +1% | +$2.79K | 0.01% | 360 |
|
2021
Q1 | $238K | Sell |
504
-264
| -34% | -$125K | 0.01% | 353 |
|
2020
Q4 | $371K | Buy |
768
+50
| +7% | +$24.2K | 0.01% | 321 |
|
2020
Q3 | $402K | Buy |
+718
| New | +$402K | 0.01% | 272 |
|
2020
Q1 | $344K | Sell |
704
-50
| -7% | -$24.4K | 0.01% | 263 |
|
2019
Q4 | $283K | Hold |
754
| – | – | 0.01% | 318 |
|
2019
Q3 | $209K | Hold |
754
| – | – | 0.01% | 331 |
|
2019
Q2 | $236K | Sell |
754
-150
| -17% | -$47K | 0.01% | 321 |
|
2019
Q1 | $371K | Hold |
904
| – | – | 0.01% | 286 |
|
2018
Q4 | $338K | Hold |
904
| – | – | 0.01% | 284 |
|
2018
Q3 | $365K | Buy |
904
+4
| +0.4% | +$1.62K | 0.01% | 306 |
|
2018
Q2 | $310K | Sell |
900
-29
| -3% | -$9.99K | 0.01% | 315 |
|
2018
Q1 | $320K | Hold |
929
| – | – | 0.01% | 302 |
|
2017
Q4 | $349K | Sell |
929
-37
| -4% | -$13.9K | 0.01% | 291 |
|
2017
Q3 | $432K | Buy |
966
+37
| +4% | +$16.5K | 0.02% | 271 |
|
2017
Q2 | $456K | Buy |
929
+29
| +3% | +$14.2K | 0.02% | 269 |
|
2017
Q1 | $349K | Buy |
+900
| New | +$349K | 0.01% | 289 |
|